Vandana Singh - Spark Newswire

1 minute read

AstraZenceca’s Tagrisso Shows Survival Benefit In Early-Stage Lung Cancer Settings

Today, 7:38 PM

AstraZeneca Plc (NASDAQ:AZN) released topline data from the ADAURA Phase 3 trial demonstrating Tagrisso (osimertinib) demonstrated a statistically significant and clinically meaningful improvement…

AZN

1 minute read

AstraZeneca’s Immunotherapy Imfinzi Shows Improvement In Survival Chances In Lung Cancer Patients

By Vandana Singh

Today, 7:38 PM

In a trial, lung cancer patients treated with AstraZeneca plc’s (NASDAQ:AZN) immunotherapy Imfinzi (durvalumab) pre- and post-surgery lived significantly longer without the…

AZN

2 minute read

Florida Republicans Propose Six-Week Abortion Ban, Further Narrowing Abortion Access

By Vandana Singh

Today, 7:38 PM

Florida Republicans introduced a bill to ban abortion after six weeks of pregnancy, offering exemptions for victims of rape and incest cases.

WBA

1 minute read

CEL-SCI’s Lead Head & Neck Cancer Candidate Shows 43% Survival Extension

By Vandana Singh

Today, 7:38 PM

CEL-SCI Corporation (NASDAQ:CVM) reported new data from its pivotal Phase 3 study of Multikine (Leukocyte Interleukin) in newly diagnosed locally advanced…

CVM

1 minute read

FDA Removes Regulatory Overhang From Inhibikase Therapeutics Parkinson, Atrophy Program

By Vandana Singh

Today, 7:38 PM

The FDA lifted the full Clinical Hold on Inhibikase Therapeutics Inc’s (NASDAQ:IKT) IkT-148009, the company’s c-Abl inhibitor, in Multiple System…

IKT

1 minute read

RenovoRx’s Targeted Pancreatic Cancer Treatment Shows Positive Trend In Median Overall Survival Versus Standard Care

By Vandana Singh

Today, 7:38 PM

RNXT

1 minute read

Mesoblast’s Lead Drug Candidate Goes Under FDA Priority Review For Bone Marrow Transplant Complications In Kids

By Vandana Singh

Today, 7:38 PM

Mesoblast Ltd (NASDAQ:MESO) rallied after the FDA agreed to review the company’s lead drug candidate, remestemcel-L, on a priority basis, more…

MESO

1 minute read

Covis Pharma To Withdraw Only FDA-Approved Treatment To Prevent Preterm Births

By Vandana Singh

Today, 7:38 PM

Privately held-Covis Pharma, the maker of Makena (hydroxyprogesterone caproate injection) to reduce the risk of preterm birth, said…

IBB

1 minute read

Health Care ETFs Have Lost In The Last Month – These Top Pharma Stocks Are The Reason

By Vandana Singh

Today, 7:38 PM

The Health Care Select Sector SPDR Fund (NYSE:XLV), heavily tilted towards mega-caps, lost around 5.25% over the last month, with substantial companies…

ABBV

1 minute read

Analyst Downgrades Gossamer Bio As Merck’s Sotatercept Might Overshadow Seralutinib’s Success

By Vandana Singh

Today, 7:38 PM

Raymond James has downgraded Gossamer Bio Inc (NASDAQ:GOSS) to Market Perform from Outperform following the publication of sotatercept’s Phase 3 data in NEJM. …

GOSS